Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population Pharmacokinetics of Posaconazole and Intelligent Dosing Decision System in Invasive Fungal Disease
ChiCTR2500101166Phase 4Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of posaconazole in invasive mycoses (2 arms), sponsored by Nanjing Drum-Tower Hospital. Primary endpoint: Posaconazole blood concentration after ≥5 days of dosing. Planned start Apr 2025; status: not yet recruiting.
02
Drugs
posaconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on ChiCTR2500101166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101166.